Apimeds Pharmaceuticals US, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Matawan, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 1-25 of 118 matching filings.

Per page
25
Current page
1
10-Q File 001-42545

QUARTERLY REPORT

Filing date
26 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date
07 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
05 May 2026
Reporting date
05 May 2026
Next action
Verify source filing
10-K File 001-42545

ANNUAL REPORT

Filing date
04 May 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
04 May 2026
Reporting date
24 Apr 2026
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
16 Apr 2026
Reporting date
15 Apr 2026
Next action
Verify source filing
425 File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date
09 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date
09 Apr 2026
Reporting date
20 Mar 2026
Next action
Verify source filing
NT 10-K File 001-42545

NOTIFICATION OF LATE FILING

Filing date
31 Mar 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date
30 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
26 Mar 2026
Reporting date
20 Mar 2026
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
25 Mar 2026
Reporting date
20 Mar 2026
Next action
Verify source filing
SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date
20 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
16 Mar 2026
Reporting date
16 Mar 2026
Next action
Verify source filing
DEFM14C File 001-42545

INFORMATION STATEMENT

Filing date
27 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-42545

AMENDMENT NO. 2 TO FORM 8-K

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-42545

AMENDMENT NO. 2 TO FORM 8-K

Filing date
17 Feb 2026
Reporting date
01 Dec 2025
Next action
Verify source filing
SCHEDULE 13G File 005-95043

SCHEDULE 13G filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-95043

SCHEDULE 13D/A filing

Filing date
26 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14C File 001-42545

INFORMATION STATEMENT

Filing date
16 Jan 2026
Reporting date
16 Jan 2026
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
10 Dec 2025
Reporting date
05 Dec 2025
Next action
Verify source filing
8-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 8-K

Filing date
10 Dec 2025
Reporting date
01 Dec 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .